Anti-infection
-
BA2270 PomotrelvirSummary: Pomotrelvir (PBI-0451) is a selective, orally active 3CL protease inhibitor. - BA2272 CCF0058981Summary: CCF0058981 (CCF981) is a 3-chlorophenyl analog, a non-covalent inhibitor.
- BA2274 TH1217Summary: TH1217 (ZINC1775962367) is a potent and selective inhibitor.
- BA2275 CichoriinSummary: Cichoriin is significantly active for.
- BA2277 XR8-89Summary: XR8-89 is a potent papain-like inhibitor.
- BA2279 X77Summary: X77 is a potent non-covalent bond inhibitor of the SARS-CoV-2 protease.
- BA2280 GRL-0496Summary: GRL-0496 is a potent chloropyridine ester-derived inhibitor.
- BA2281 BamlanivimabSummary: Bamlanivimab (Anti-HumanSARS-CoV-2) is the first COVID-19 monoclonal antibody (mAb) to receive Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) in November 2020.
- BA2282 YH-53Summary: YH-53 is a potent inhibitor.
- BA2283 MM3122Summary: MM3122 is a selective inhibitor of type II transmembrane serine proteases.